Cingulate Inc. - 8-K Filing

Cingulate Inc. extended the trial period for its CMO to December 31, 2026 and revised his base salary. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No)

SEC EDGAR ·

Tickers: $CING

Read the full article at SEC EDGAR

Part of the story TriplePoint Venture Growth BDC Corp. - 8-K Filing (197 articles)

More Regulatory news